Channing Capital Management’s PVH PVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-680,991
| Closed | -$72M | – | 119 |
|
|
2024
Q4 | $72M | Buy |
680,991
+316,876
| +87% | +$32.5M | 1.92% | 24 |
|
|
2024
Q3 | $36.7M | Sell |
364,115
-281,791
| -44% | -$28M | 0.94% | 43 |
|
|
2024
Q2 | $68.4M | Buy |
645,906
+44,144
| +7% | +$4.99M | 1.88% | 30 |
|
|
2024
Q1 | $84.6M | Buy |
601,762
+20,473
| +4% | +$2.62M | 2.27% | 8 |
|
|
2023
Q4 | $71M | Buy |
581,289
+503,586
| +648% | +$45.1M | 2.09% | 18 |
|
|
2023
Q3 | $5.95M | Buy |
77,703
+7,822
| +11% | +$647K | 0.2% | 86 |
|
|
2023
Q2 | $5.94M | Sell |
69,881
-22,145
| -24% | -$1.87M | 0.18% | 98 |
|
|
2023
Q1 | $8.21M | Buy |
+92,026
| New | +$7.51M | 0.26% | 75 |
|
|
2022
Q1 | – | Sell |
-734,929
| Closed | -$78.4M | – | 115 |
|
|
2021
Q4 | $78.4M | Buy |
734,929
+45,494
| +7% | +$4.97M | 2.22% | 11 |
|
|
2021
Q3 | $70.9M | Buy |
689,435
+6,791
| +1% | +$731K | 2.2% | 7 |
|
|
2021
Q2 | $73.4M | Buy |
682,644
+43,574
| +7% | +$4.79M | 2.42% | 7 |
|
|
2021
Q1 | $67.5M | Buy |
639,070
+189,584
| +42% | +$18.7M | 2.31% | 10 |
|
|
2020
Q4 | $42.2M | Sell |
449,486
-192,988
| -30% | -$14.7M | 1.72% | 26 |
|
|
2020
Q3 | $38.3M | Buy |
642,474
+108,793
| +20% | +$5.99M | 2.08% | 11 |
|
|
2020
Q2 | $25.6M | Buy |
533,681
+456,898
| +595% | +$21.3M | 1.47% | 33 |
|
|
2020
Q1 | $2.89M | Buy |
76,783
+38,284
| +99% | +$2.93M | 0.2% | 93 |
|
|
2019
Q4 | $4.05M | Sell |
38,499
-64,789
| -63% | -$6.18M | 0.19% | 107 |
|
|
2019
Q3 | $9.11M | Buy |
103,288
+27,958
| +37% | +$2.34M | 0.42% | 66 |
|
|
2019
Q2 | $7.13M | Buy |
75,330
+1,598
| +2% | +$177K | 0.33% | 75 |
|
|
2019
Q1 | $8.99M | Sell |
73,732
-5,062
| -6% | -$554K | 0.41% | 57 |
|
|
2018
Q4 | $7.32M | Buy |
78,794
+16,365
| +26% | +$1.87M | 0.37% | 71 |
|
|
2018
Q3 | $9.02M | Buy |
+62,429
| New | +$9.23M | 0.32% | 65 |
|
|
2017
Q1 | – | Sell |
-123,767
| Closed | -$11.2M | – | 112 |
|
|
2016
Q4 | $11.2M | Sell |
123,767
-23,281
| -16% | -$2.45M | 0.4% | 64 |
|
|
2016
Q3 | $16.2M | Sell |
147,048
-65,729
| -31% | -$6.8M | 0.65% | 50 |
|
|
2016
Q2 | $20.1M | Sell |
212,777
-2,792
| -1% | -$262K | 0.84% | 44 |
|
|
2016
Q1 | $21.4M | Buy |
215,569
+5,090
| +2% | +$401K | 0.95% | 40 |
|
|
2015
Q4 | $15.5M | Buy |
210,479
+25,622
| +14% | +$2.27M | 0.69% | 53 |
|
|
2015
Q3 | $18.8M | Buy |
184,857
+7,890
| +4% | +$897K | 0.92% | 47 |
|
|
2015
Q2 | $20.4M | Buy |
176,967
+12,175
| +7% | +$1.32M | 0.91% | 49 |
|
|
2015
Q1 | $17.6M | Sell |
164,792
-12,057
| -7% | -$1.31M | 0.8% | 51 |
|
|
2014
Q4 | $22.7M | Buy |
176,849
+9,054
| +5% | +$1.09M | 1.16% | 43 |
|
|
2014
Q3 | $20.3M | Sell |
167,795
-7,434
| -4% | -$871K | 1.22% | 38 |
|
|
2014
Q2 | $20.4M | Buy |
175,229
+30,729
| +21% | +$3.82M | 1.21% | 44 |
|
|
2014
Q1 | $18M | Buy |
144,500
+10,326
| +8% | +$1.27M | 1.15% | 43 |
|
|
2013
Q4 | $18.3M | Buy |
134,174
+1,777
| +1% | +$226K | 1.2% | 44 |
|
|
2013
Q3 | $15.7M | Sell |
132,397
-134
| -0.1% | -$17.2K | 1.16% | 46 |
|
|
2013
Q2 | $16.6M | Buy |
+132,531
| New | +$15.2M | 1.49% | 10 |
|
Other funds holding PVH
Channing Capital Management's PVH Position: Q1 2025 in Review
Channing Capital Management sold out of PVH (PVH) in Q1 2025, closing a stake of 680,991 shares — an estimated $72M sold.
Channing Capital Management first reported a position in PVH in Q2 2013 and held it in 37 quarters. The position peaked at $84.6M in Q1 2024. 369 funds tracked by Wall St. Rank hold PVH as of Q1 2025.
- Channing Capital Management reported no remaining PVH position as of Q1 2025 after selling out during the quarter.
- Channing Capital Management sold 680,991 PVH shares in Q1 2025, an estimated $72M.
- Channing Capital Management first reported a position in PVH in Q2 2013 and held it in 37 quarters.
- Channing Capital Management's PVH position peaked at $84.6M in Q1 2024.
- 369 funds tracked by Wall St. Rank held PVH as of Q1 2025.
Based on Channing Capital Management's 13F filing for Q1 2025, filed 14 May 2025.